Avecia
Manufacturing · Massachusetts, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
33 Locke Dr, Marlborough, Massachusetts,...Phone Number
(508) 532-2500Website
www.avecia.comRevenue
$39.3 MillionIndustry
About Avecia
Nitto Avecia specializes in comprehensive oligonucleotide solutions, offering services that range from preclinical manufacturing to drug substance manufacturing. With over 25 years of experience, they provide analytical development, process development, and quality control services tailored for the pharmaceutical industry. Their intended clients include companies involved in oligonucleotide programs seeking robust and cost-effective manufacturing processes. Nitto Avecia is committed to quality assurance and technological innovation in the biopharmaceutical sector.Explore more
Avecia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Avecia
Compare insights from companies similar to Avecia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avecia Tech Stack
A closer look at the technologies used by Avecia
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avecia
Sign Up For FreeTo access detailed company insights
Nitto Avecia specializes in comprehensive oligonucleotide solutions, offering services that range from preclinical manufacturing to drug substance manufacturing. With over 25 years of experience, they provide analytical development, process development, and quality control services tailored for the pharmaceutical industry. Their intended clients in... Read More
